Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × TAK-981 × Clear all

NCT03648372 2024-11-19

A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Phase 1/2 Terminated

109 enrolled 54 charts

LymphoidOther hematologic neoplasm

Lymphoma, Neoplasms, Hematologic Neoplasms